D
Zai Lab Limited ZLAB
$37.29 $1.153.18%
Recommendation
Sell
Prev Close
$37.29
Volume
2,472,258
Avg Vol (90D)
894,591
Market Cap
$4.07B
Dividend & Yield
--
52-Week Range
$13.48 - $39.77
P/E (TTM)
--
EPS (TTM)
-$25.92
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Zai Lab (NASDAQ:ZLAB) Stock Price Up 2.9% - What's Next?
4/1/2025 - Ticker Report
Zai Lab (NASDAQ:ZLAB) Hits New 1-Year High - What's Next?
3/29/2025 - MarketBeat
Zai Lab (ZLAB, $37.29) entered Downtrend as Momentum indicator drops below 0 level on Mar 28, 2025
3/29/2025 - Tickeron - Technical Analysis
Zai Lab (NASDAQ:ZLAB) Shares Gap Up - Here's What Happened
3/28/2025 - MarketBeat
Zai Lab (NASDAQ:ZLAB) Hits New 1-Year High - What's Next?
3/28/2025 - Ticker Report
Cantor Fitzgerald Reaffirms Overweight Rating for Zai Lab (NASDAQ:ZLAB)
3/28/2025 - MarketBeat
Zai Lab Limited Reports Strong Revenue Growth and Reduced Losses in 2024
3/27/2025 - TipRanks Financial Blog
Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last week, although long-term gains have benefitted them.
3/27/2025 - Simply Wall St
Zai Lab (NASDAQ:ZLAB) Receives "Overweight" Rating from Cantor Fitzgerald
3/27/2025 - Ticker Report
Zai Lab (ZLAB, $33.91) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2025
3/27/2025 - Tickeron - Technical Analysis
Zai Lab Ltd (ZLAB) to Present Promising Oncology Therapies at AACR 2025
3/26/2025 - GuruFocus
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at ...
3/26/2025 - GuruFocus
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting
3/26/2025 - Business Wire
Zai Lab (NASDAQ:ZLAB) Shares Gap Down - Time to Sell?
3/22/2025 - MarketBeat
Zai Lab (ZLAB, $35.09) entered Downtrend as Momentum indicator drops below 0 level on Mar 21, 2025
3/22/2025 - Tickeron - Stocks
Zai Lab (ZLAB, $35.09) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 21, 2025
3/22/2025 - Tickeron - Stocks
Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth
3/21/2025 - SeekingAlpha
Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth
3/21/2025 - Seeking Alpha - Long Ideas
Zai Lab Limited (NASDAQ:ZLAB) Insider Rafael Amado Sells 3,000 Shares
3/20/2025 - MarketBeat
Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks
3/20/2025 - Seeking Alpha - Long Ideas
Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks
3/20/2025 - SeekingAlpha
Rafael Amado Sells 3,000 Shares of Zai Lab Limited (NASDAQ:ZLAB) Stock
3/20/2025 - MarketBeat
Privium Fund Management B.V. Has $4.85 Million Position in Zai Lab Limited (NASDAQ:ZLAB)
3/20/2025 - MarketBeat
Rafael Amado Sells 3,000 Shares of Zai Lab Limited (NASDAQ:ZLAB) Stock
3/19/2025 - Zolmax
Zai Lab (ZLAB, $37.92) RSI Indicator left the overbought zone on March 18, 2025
3/19/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$398.99M
EBITDA (TTM)
-$270.26M
EBIT (TTM)
-$282.12M
Net Income (TTM)
-$257.10M
Balance Sheet
Total Assets (Q)
$1.19B
Total Debt (Q)
$153.47M
Total Liabilities (Q)
$344.86M
Book Value Per Share (Q)
$78.03
Cash Flow
Cash from Operations (TTM)
-$214.87M
Cash from Investing (TTM)
-$375.19M
Cash from Financing (TTM)
$349.89M
Net Change in Cash (TTM)
-$240.48M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.08
7-Day Total Return
-0.11%
30-Day Total Return
28.59%
60-Day Total Return
42.38%
90-Day Total Return
37.80%
Year to Date Total Return
50.30%
1-Year Total Return
123.03%
2-Year Total Return
6.42%
3-Year Total Return
-17.48%
5-Year Total Return
-29.60%
52-week Low
Apr 18, 2024 - $13.48
52-week High
Mar 28, 2025 - $39.77
Valuation
Market Cap
$4.07B - Mid Cap
Enterprise Value
$3.44B
Price/Sales (TTM)
0.96
Price/Book (Q)
0.48
Dividends and Shares
Shares Outstanding
10.27M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.zailaboratory.com
Phone Number
86 21 6163 2588
Address
Jinchuang Plaza
Building 1, Fourth Floor - 4560 Jinke Road
Pudong Shanghai, 201210
Country
China
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Zai Lab Limited develops and commercializes products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include... more
NASDAQ 04/01/2025 4:00PM Eastern Quotes delayed
Weiss Ratings